Ameritas Advisory Services LLC Acquires 2,508 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Ameritas Advisory Services LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 9.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 29,094 shares of the financial services provider’s stock after buying an additional 2,508 shares during the quarter. Ameritas Advisory Services LLC owned about 0.06% of iShares Biotechnology ETF worth $3,847,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in IBB. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $29,000. Highline Wealth Partners LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $30,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Modus Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $41,000. Finally, Voisard Asset Management Group Inc. bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $59,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $132.65 on Monday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock’s 50 day moving average is $136.62 and its 200 day moving average is $141.86.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.